(7alpha)-3-Hydroxy-7-methylestra-1,3,5(10)-trien-17-one(CAS: 10448-96-1)

The compound (7alpha)-3-Hydroxy-7-methylestra-1,3,5(10)-trien-17-one (CAS: 10448-96-1) is subject to regulatory guidelines under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations in the European Union, and FDA/EPA requirements in the United States. It must be classified and labelled according to its hazardous properties, and proper documentation and reporting are required for its use, storage, and disposal.

Alternatives to (7alpha)-3-Hydroxy-7-methylestra-1,3,5(10)-trien-17-one (CAS: 10448-96-1) in synthesis include other estrane derivatives or related compounds with similar functional groups. Common alternative reagents include 17α-hydroxyprogesterone or other estradiol derivatives, which can be used as starting materials or intermediates in synthetic pathways.

The market for (7alpha)-3-Hydroxy-7-methylestra-1,3,5(10)-trien-17-one (CAS: 10448-96-1) is primarily driven by research and development in pharmaceuticals and hormone-based therapies. Recent trends indicate increased interest in natural hormone analogs and their applications in reproductive health, fertility treatments, and hormone replacement therapy. Additionally, there is growing research on the potential of estrane derivatives in anti-inflammatory and anti-cancer applications.

Waste containing (7alpha)-3-Hydroxy-7-methylestra-1,3,5(10)-trien-17-one (CAS: 10448-96-1) should be collected in appropriate containers lined with absorbent material to prevent spillage and dispersion. Proper labeling is essential to indicate the hazardous nature of the waste. The waste should then be disposed of through professional waste disposal services that adhere to regulatory guidelines. Environmental protection measures include ensuring the waste is not released into the environment and that any cleanup is conducted safely and effectively.